Javier Menarguez
Overview
Explore the profile of Javier Menarguez including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
52
Citations
866
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Salmeron-Villalobos J, Castrejon-de-Anta N, Guerra-Garcia P, Ramis-Zaldivar J, Lopez-Guerra M, Mato S, et al.
Blood
. 2023 Apr;
142(5):434-445.
PMID: 37053555
Posttransplant lymphoproliferative disorders (PTLDs) represent a broad spectrum of lymphoid proliferations, frequently associated with Epstein-Barr virus (EBV) infection. The molecular profile of pediatric monomorphic PTLDs (mPTLDs) has not been elucidated,...
2.
Bastos-Oreiro M, Sanz-Villanueva L, Muniz P, Bailen R, Chicano M, Oarbeskoa G, et al.
Transplant Cell Ther
. 2023 Mar;
29(7):472.e1-472.e4.
PMID: 36921917
We propose a novel biomarker that can identify patients at high risk of early progression after chimeric antigen receptor (CAR) T cell therapy. Calculation of cell-free DNA (cfDNA) with a...
3.
Baptista M, Tapia G, Munoz-Marmol A, Muncunill J, Garcia O, Montoto S, et al.
Histopathology
. 2022 Sep;
81(6):826-840.
PMID: 36109172
The frequency of aggressive subtypes of B-cell non-Hodgkin lymphoma (B-NHL), such as high-grade B-cell lymphomas (HGBL) with MYC and BCL2 and/or BCL6 rearrangement (HGBL-DH/TH) or Burkitt-like lymphoma (BL) with 11q...
4.
Martin-Rojas R, Gomez-Centurion I, Bailen R, Bastos M, Diaz-Crespo F, Carbonell D, et al.
Clin Case Rep
. 2022 Jan;
10(1):e05209.
PMID: 35028140
Chimeric antigen receptor (CAR) T cell-related HLH/MAS is an unusual manifestation of severe cytokine release syndrome (CRS) with poor prognosis and a challenging diagnosis. The establishment of specific diagnosis criteria...
5.
Bastos-Oreiro M, Suarez-Gonzalez J, Andres-Zayas C, Carrion N, Moreno S, Carbonell D, et al.
Sci Rep
. 2021 Nov;
11(1):22815.
PMID: 34819573
Although next-generation sequencing (NGS) data on lymphomas require further validation before being implemented in daily practice, the clinical application of NGS can be considered right around the corner. The aim...
6.
Frontzek F, Staiger A, Zapukhlyak M, Xu W, Bonzheim I, Borgmann V, et al.
Nat Commun
. 2021 Sep;
12(1):5183.
PMID: 34465776
Plasmablastic lymphoma (PBL) represents a rare and aggressive lymphoma subtype frequently associated with immunosuppression. Clinically, patients with PBL are characterized by poor outcome. The current understanding of the molecular pathogenesis...
7.
Muniz P, Kwon M, Carbonell D, Chicano M, Bailen R, Oarbeascoa G, et al.
Front Immunol
. 2021 Apr;
12:642087.
PMID: 33841425
Haploidentical hematopoietic stem cell transplantation (Haplo-HSCT) with high-dose cyclophosphamide (PTCy) has resulted in a low incidence of graft-vs.-host disease (GVHD), graft failure, and non-relapse mortality. However, post-transplantation relapse remains a...
8.
Boiza-Sanchez M, Manso R, Balague O, Chamizo C, Askari E, Salgado R, et al.
PLoS One
. 2020 Nov;
15(11):e0241634.
PMID: 33180881
Aim: Lymphoplasmacytic lymphoma (LPL) is an indolent mature B-cell-neoplasm with involvement of the bone marrow. At least 90% of LPLs carry MYD88-L265P mutation and some of them (~10%) transform into...
9.
Gonzalez-Gascon Y Marin I, Menarguez J, Kwon M, Burdaspal A, Martinez-Laperche C, Castro Y, et al.
Appl Immunohistochem Mol Morphol
. 2019 Apr;
28(10):e94-e98.
PMID: 30973352
We report 2 cases of composite lymphoma comprising mantle cell lymphoma and peripheral T-cell lymphoma, not otherwise specified, a rare association that has only been reported twice in the literature....
10.
Gonzalez-Rincon J, Mendez M, Gomez S, Garcia J, Martin P, Bellas C, et al.
PLoS One
. 2019 Feb;
14(2):e0212813.
PMID: 30802265
Follicular lymphoma (FL) is an indolent but largely incurable disease. Some patients suffer histological transformation to a more aggressive subtype with poorer prognosis. This study aimed to improve our understanding...